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Warfarin is the most used anticoagulant in primary health care. Due to the narrow therapeutic index, its 
users are more susceptible to adverse events. The objective of this study was to describe the itinerary of 
the public health sector patients for resolution of adverse events related to warfarin. It is a prospective 
open cohort, held for a period of 18 months with warfarin users of the Brazilian public health system. 
Data were collected by monthly interviews and from patient records. Results: Sixty nine patients were 
interviewed, 64 of them completed monitoring and five died. Bleeding and venous thromboembolism 
were more frequent in patients starting treatment. It was observed that when adverse events have 
occurred, in most cases the patient held self-care at home (57%). During the follow-up, five patients 
were hospitalized for bleeding. Approximately half of the patients did not present their INR exams to 
the doctor. Conclusions: This study demonstrates weaknesses in caring for these patients and the need 
to accompany them, aiming to standardize and guide the itinerary of the anticoagulated patient to solve 
their problems and improve safety in drug treatment, with less cost to the public health system.
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INTRODUCTION
Therapeutic itineraries are conceptualized as the 
route taken by individuals or groups, in order to preserve 
or restore health, and can be used for different features, 
ranging from home care and religious practices to the 
primary health care, health care emergencies, among 
others (Cabral, 2011). 
According to Oliveira and colleagues (2014) 
studies on users´s itineraries in search of health care 
can significantly contribute to the understanding of 
the behavior during treatment, as well as the use of 
health services, representing an important tool for the 
improvement of health assistance. Studies on therapeutic 
itineraries are relatively recent in Brazil (Cabral, 2011) 
and have been more frequent in developing countries 
(Diop et al., 2014), where there is greater concern about 
rationalizing health care. 
The study of therapeutic itineraries can be applied 
for different diseases (Pereira et al., 2014; Silva et al., 
2012; Soares, Santos, Arruda, 2017) and for the use of 
drugs (Bueno, Guerin, Rossoni, 2014), like warfarin. This 
medication is associated with the risk of adverse events, 
due to its narrow therapeutic index, variable dose-response 
and numerous drug interactions (Ansell et al., 2005). 
Adverse events arising from interactions range from 
small bleeds to severe bleeding, requiring hospitalizations 
(Simon et al., 2016). The incidence of bleeding ranges from 
4.6 to 15.4 reactions/100 patients/year, whereas embolic 
events range from 0.75 to 2.57 reactions/100 patients/year 
(Cressman et al., 2015; Labaf et al., 2014; Benhamou et 
al., 2009; Pastori et al., 2015). 
Warfarin is the oral anticoagulant of choice in the 
Brazilian public health system (Brazil, 2017). One of 
the determining factors for its election is the low cost in 
relation to drugs recently introduced in the market (Silva, 
2012). 
Because of the adverse events, warfarin is associated 
with hospital admissions and increased search for health 
services (Howard et al., 2007) showing the importance of 
exploring the therapeutic itinerary of patients using this 
drug.
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It is essential to know how these users access the 
health service for the resolution of adverse events in 
the different levels of care. This knowledge can support 
actions for care reorganization and raising new studies and 
insights on the subject. Thus, the aim of this study is to 
describe the therapeutic itinerary of patients in the public 




Data were obtained through a prospective open 
cohort, which included individuals using warfarin linked 
to the network of public health system of Ijuí, south of 
Brazil. 
Municipal Pharmaceutical Services offers 15 
places where drugs are dispensed linked to Basic Health 
Units (BHU). Dispensing is performed by pharmacy 
attendants/trainees, without supervision of a pharmacist. 
The municipality does not have computerized system for 
dispensing drugs, then the prescription copy, stored in the 
Central Pharmacy of the Municipal Secretariat of Health 
(SMS), was accessed for information. 
All prescriptions which contained warfarin were 
selected. Later, it was identified among the network 
drug dispensing units, the one where the user takes his/
her drugs. With this information, patients’ charts were 
accessed, allowing the identification of the residential 
address, telephone data, and so, the scheduling of home 
visits. With this information, patients’ charts were 
accessed, allowing the identification of the residential 
address, telephone data, and so, the scheduling of home 
visits.
 The identification of the participants took place in 
February 2014. The follow up of patients was done for 
a maximum period of 18 months and a minimum of 12 
months, between April 2014 and October 2015. In the first 
six months (until October 2014) there was recruitment of 
new patients starting warfarin use. 
Were included all patients using warfarin orally, for 
chronic treatment, living in the city of Ijuí/RS, which were 
outcome-free at baseline. Moreover, they would had to 
withdrew their medicines in the public health system, and 
sign the Terms of Consent. In the first home visit, patients 
were excluded if: reported being from other municipalities, 
had exchanged anticoagulant or had purchased their drugs 
in private services. In case of bedridden patients with 
speech difficulties, interviews were carried out with the 
caregiver or guardian. 
Data collection and study procedures
Data collection was performed using an instrument 
previously tested and developed specially for this research. 
The questionnaire investigates aspects related to the 
patient (socioeconomic and demographic characteristics), 
to the use and prescription of warfarin (duration of use, 
dose, schedule of administration, prescriber specialty, 
information provided by the doctor about this medication 
and regular medical consultation), and to the search for 
medical care (access to health services, considering: 
BHU, Emergency Room/Emergency and Hospital and 
reason to search). Monthly, patients were asked whether 
they had presented any adverse event, such as bleeding 
and thromboembolism, and also what kind of health care 
they had used in these situation (home care and/or health 
services listed above).
Health problems and adverse events were referred 
by the patients in the first interview and monitored during 
monthly visits. Adverse events were also obtained by self-
report, confirmed later with access to medical records, 
when the patient sought medical or hospital care. 
In 3rd, 10th and 18th months, blood samples were 
taken and the INR (International Normalized Ratio) was 
evaluated. The test results were delivered to users and, in 
the subsequent interview, users were asked whether they 
had shown the tests to the doctor. 
Data analysis 
The therapeutic routes carried out by patients were 
classified as: a) self-care at home; b) Basic Health Units; 
c) Emergency and d) Hospitalization.
Data were analyzed by SPSS software 18 version 
and presented as frequencies, measures of central tendency 
and dispersion of the sample (SPSS, 2009). 
Ethical aspects
All study participants signed the Terms of Consent. 
The project was approved by the Committee of Ethics in 
Research of the Federal University of Rio Grande do Sul, 
under identification No. 336.259/2013. 
RESULTS
Of 98 patients with prescription of warfarin, 
69 users were located and interviewed. The flow chart 
1 presents details about losses and refusals. Most of the 
patients were of the female gender, with an average age 
of 64.3 ± 13.7. Data are presented in Table I. 
For data analysis, the patients were divided into 
beginners (n = 17/25%) and in use of warfarin for 
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more than one year (n = 51/75%) (Figure 1). During 
the study period, 88 events of bleeding and 5 events of 
thromboembolism were observed. These events were 
more frequent among beginner patients, with 31 cases 
of bleeding and 5 of thromboembolism. Furthermore, 
all patients who died (four by thromboembolism and 
one by bleeding) were patients with more than one year 
of warfarin use, elderly, polymedicated and presenting 
comorbidities. 
Figure 1 and 2 show the itinerary data of patients 
to the resolution of the adverse events described above. 
It was observed that 12.9% sought at first care in Basic 
Health Units. Among those who have opted for self-care 
at home (57.0%), 16 (26.2%) reported that they held local 
asepsis and bandage; one of them (1.6%) was concerned in 
monitoring the situation and other one (1.6%) suspended 
the use of warfarin. It was found that most of them opted 
for self-care at home, reporting already taken this conduct 
in previous events or the difficulty of access to health 
services. It was noticed that part of the patients did not 
understand the gravity of the situation and the need to 
get help. 
Also, Figure 2 shows that five (7.3%) patients were 
hospitalized for bleeding or thrombosis, 7 (10.3%) initially 
sought the emergency service and after were hospitalized. 
In some cases, patients adopted self-care as first care, but 
after it was necessary to seek for Health Unit (9.7%) and/or 
Emergency Service (7.6%) to resolve the problem.
Most patients (91.0%) reported that warfarin was 
prescribed by an expert, however, subsequent prescriptions 
and dosage adjustments are usually made by doctors that 
work at Basic Health Units. Among the patients who 
reported medical consultations in the follow-up period 
(68.1%), most (47.0%) had one to three appointments.. 
Regarding the fact of showing the results of INR 
tests to the doctor, this procedure was adopted by 52.2% of 
patients after the first examination, 57.9% after the second 
examination and 40.6% after the third examination. The 
dose of warfarin has changed in 46.2% of cases in which 
patients have shown the test results to the doctor. Table II 
shows the number of INR tests performed per year. Most 
patients (73.5%) held from one to five INR tests, including 
the three of them carried out by the research. 
There were shortages of warfarin in public municipal 
health system between the months 13 and 16. It was found 
that 24.9% to 43.5% of patients, depending on the month, 
did not acquire the medicine for this lack. 
DISCUSSION
One of the results observed in this study was 
the high incidence of adverse events, as bleeding, 
thromboembolism and death. Gado and colleagues (2015) 
highlight that adverse effects of medicines are related to: 
lack of knowledge of the patient about his illness and 
medication; forgetfulness; social and economic factors, 
and adherence. 
It can be seen that new warfarin users experienced 
more bleeding events and venous thromboembolism. 
According to the literature, the greatest risk of bleeding 
among users of warfarin occurs within the first 30 days 
of therapy (Kelling et al., 2011). It was observed that 
beginners seek more medical service as a result of adverse 
events than patients with more time of use. However, the 
number of regular consultations was not higher in this 
group. In this period, a greater number of dose adjustments 
are necessary, and it is the moment in which the patient 
needs greater attention on the part of the health care team.
It was found that the deaths occurred by bleeding or 
thromboembolism in patients treated with warfarin for one 
year or more. All had aggravating factors that should have 
been considered. The data of hemorrhagic events range 
from 4.6 to 15.4 events/100 patients/year and embolic 
TABLE I - Socioeconomic characteristics of users of the public 













Incomplete Elementary School 43 62.3
Complete Elementary School 5 7.2
Complete High School 11 15.9
Complete Higher Education 10 14.5
Income
1 SM 36 52.2
2 SM 20 28.9
3 SM 7 10.2
> 3SM 6 8.7
* Responses obtained in the first month of patients follow-up
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FIGURE 1 - Itinerary of patients for the resolution of adverse events, according to the warfarin use of time and level of attention 
to every six months in cohort monitoring in the city of Ijuí/RS. n = 69
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event contents ranged from 0.75 to 2.57 events/100 
patients/year (Labaf et al., 2014; Pastori et al., 2015). 
These data demonstrate the need for greater monitoring of 
this drug, considering it’s chronic use and that the adverse 
events could be avoided. 
When the patients in this study were affected by 
adverse events, the most adopted conduct was home self-
care, indicating that part of the respondents usually take 
care of their health first on their own, using the informal 
health system. The fact that patients try to delay search for 
help in the Health Units has been pointed out by anotheres 
studies (Dræbel, Gueth, 2014; Ouendo et al., 2005; 
Schoze, Silva, 2005). However, the severity of events can 
be a determining factor to define the therapeutic itinerary. 
It should be noted, in this regard, the need to establish lines 
of care for anticoagulated patients in the municipality, 
through the elaboration of municipal protocols, in order to 
create a network of assistance in cases of adverse events 
and seeking a constant and continuous monitoring to 
prevent these events. 
The highest percentage observed for the conduct of 
home self-care may be related to the severity of the events, 
but also indicates the need for improvement in education 
actions for the patients to have more autonomy and control 
their treatment, that has proved effective for anticoagulated 
patients (Ouendo et al., 2005). 
The difficulty in accessing to health services was 
one of the reasons why some patients opted for home self-
care for bleeding. The study of Schoze and Silva (2005) 
showed that the greatest difficulty of the respondents 
referred to the opening hours of the Health Center and 
the difficulty in scheduling appointments. In the present 
research, the Health Units work only during business 
hours, which may hinder the access to those patients who 
work during the day. Another factor is the limited daily 
medical consultations, which can also become a barrier 
to the anticoagulated patient presenting adverse events.
The difficulty to access the health system may result 
in a worsening of the clinical picture. This statement can 
be confirmed in the present study, as among the patients 
hospitalized for bleeding, seven of them sought first the 
Health Unit. The events were not identified and treated 
appropriately, generating the need for hospitalization. 
For Dubeux, Freese, Felisberto (2013) the main problems 
identified by users of the health system in research on the 
itinerary were: the professional did not resolve the health 
TABLE II -  Frequency of examination and conduct in relation to 
the result of the INR, in the municipality cohort of Ijuí/RS n= 69
n (%)
Number of INR tests/year* 
     1– 5 50 (72.4)
     6-10 16 (23.2)
     >10 3 (4.4)
Conduct adopted by the patient in relation to the 
result of the examination  
Took the exam to the doctor 104 (50.2)
     Change the dose 48 (46.2)
     None 49 (47.1)
     Suspension of warfarin 7 (6.7)
Did not take the exam to the doctor 103 (49.8)
     None 78 (75.7)
     Changed the dose on his/her own 20 (19.4)
     Suspended the medicine on his/her own 5 (4.9)
Note: * = 18 months of follow-up
FIGURE 2. Itinerary of patients for the resolution of bleending and thrombosis, according to the warfarin considering the level of 
attention in cohort monitoring in the city of Ijuí/RS. n = 69
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problem (59.0%), the hospital was far away from home 
(58.5%) and delay to the service (58.5%). Oliveira et al. 
(2014) points out that from the illness to the realization 
of the correct diagnosis and early specific treatment, 
patients end up walking a long way, not rarely resulting 
in hospitalization, which would be a flag of the failures 
of care that, if well managed, could stop or prevent this 
trajectory.
The need for hospitalization, pointed out in this 
study as result of bleeding also shows problems in solving 
the primary care. Primary health care has important role to 
prevent the illness, expand coverage, ensuring access of 
the population to services, providing resolute outpatient 
care, in order to avoid hospitalization and deleterious 
consequences (Oliveira et al., 2014) In this way, is a 
challenge to professionals and managers to guarantee the 
access and turn the health services resolute (Novaczyk, 
Gaiva, 2010; Hayakawa et al., 2010; Guerin, Rossoni, 
Bueno, 2012).
Research shows that the late forwarding to the 
specialist and to the start of treatment may be a factor 
responsible for emergency hospitalizations (Araújo et 
al., 2014). In the present study, the initial requirements of 
the anticoagulant were performed by specialists, but the 
following care was done by doctors that work at Basic 
Health Units. These doctors, in some cases, may not have 
a better understanding about anticoagulation and about 
monitoring the anticoagulated patient. This may influence 
treatment adherence and the resolution of adverse events. 
The low number of exams to monitor the INR can indicate 
problems in monitoring. Moreover, a study conducted in 
anticoagulation outpatient service shows lower incidence of 
adverse events than in this study (Orensky, Holdford, 2005). 
Other result that needs to be discussed is the 
conduct of some of the patients that do not take their INR 
examinations to the doctor. This data can show lack of 
commitment of the patients with their treatment, but in 
particular can be a result of ignorance of its importance and 
the difficulty of access to health services. The specialized 
clinics for treatment of anticoagulated patients already 
demonstrated its importance for INR maintenance in the 
therapeutic range, when compared with care provided 
only by family doctor (Bungard et al., 2013). Deen (2011) 
describes the reduction of risks related to the use of ACO 
in patients monitored on an anticoagulation outpatient 
service.
In anticoagulation outpatient services patients are 
assisted by a multidisciplinary team. The interdisciplinary 
approach is essential for therapeutic success because the 
establishment of individualized objectives for patients 
with multiple comorbidities and/or complicated social 
situations (Perone et al., 2012). However, the fragmented 
view of the various professionals prevails, originating 
inadequate referrals and screening (Visentin, Lenardt, 
2010). 
The resoluteness in primary care is linked to 
the instrumental resource and technical knowledge of 
professionals, and also to the link established with the user. 
(Schoze, Silva, 2005). In this way, the concern about how 
people look for help to resolve their demands or health 
problems have been increasingly present in studies on 
planning, organization and evaluation of health assistance 
services, since the user’s itinerary in the search for 
therapeutic care does not necessarily coincide with paths 
predetermined by the health system (Cabral et al., 2011).
It is noteworthy that this study is subject to inherent 
biases in observational studies. Limitations of the study 
were that information collected was self-reported by the 
patients, some patients were not located due to address 
registration problems. In addition, the drug interactions 
were not considered and bleeding was not classified 
according to severity.
 In conclusion, it was observed that patients try to 
delay going to the Health Units with the use of self-care 
to resolve adverse events of warfarin. This attitude, in 
some cases, worsens the clinical picture, requiring more 
complex services like emergency or hospitalization. 
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